
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Nup50 CRISPR/Cas9 KO Plasmid (h) | sc-406550 | 20 µg | $397.00 |
NUP50 encodes Nup50, a dynamic component of the nuclear pore complex that participates in nucleocytoplasmic transport by modulating importin-α/β–dependent cargo trafficking and recycling within the nucleus. Through its interactions at the nuclear basket, Nup50 helps coordinate nuclear import kinetics with broader processes such as cell-cycle progression, transcriptional regulation, and maintenance of nuclear architecture. Disruption of nuclear transport pathways and nuclear pore complex homeostasis is frequently implicated in genome instability and altered signaling programs relevant to cancer biology and other disorders characterized by impaired nucleocytoplasmic compartmentalization. Accordingly, NUP50 is commonly studied in the context of nuclear transport regulation, proteostasis, and stress-responsive signaling.
Nup50 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the NUP50 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the NUP50 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the NUP50 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Nup50 protein expression.
This CRISPR knockout system enables efficient generation of NUP50-deficient cell models for investigation of Nup50 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.